49 related articles for article (PubMed ID: 17768177)
1. Identification and functional characterization of ASK/Dbf4, a novel cell survival gene in cutaneous melanoma with prognostic relevance.
Nambiar S; Mirmohammadsadegh A; Hassan M; Mota R; Marini A; Alaoui A; Tannapfel A; Hegemann JH; Hengge UR
Carcinogenesis; 2007 Dec; 28(12):2501-10. PubMed ID: 17768177
[TBL] [Abstract][Full Text] [Related]
2. A UHPLC-Mass Spectrometry View of Human Melanocytic Cells Uncovers Potential Lipid Biomarkers of Melanoma.
Perez-Valle A; Abad-García B; Fresnedo O; Barreda-Gómez G; Aspichueta P; Asumendi A; Astigarraga E; Fernández JA; Boyano MD; Ochoa B
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769491
[TBL] [Abstract][Full Text] [Related]
3. Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells.
Testa U; Castelli G; Pelosi E
Med Sci (Basel); 2017 Nov; 5(4):. PubMed ID: 29156643
[TBL] [Abstract][Full Text] [Related]
4. Co-targeting of specific epigenetic regulators in combination with CDC7 potently inhibit melanoma growth.
Chava S; Bugide S; Malvi P; Gupta R
iScience; 2022 Aug; 25(8):104752. PubMed ID: 35942091
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance and potential mechanism of DBF4 zinc finger in hepatocellular carcinoma.
Wu Z; Zhang L; Li X; Liu L; Kuang T; Qiu Z; Deng W; Wang W
Sci Rep; 2024 May; 14(1):10662. PubMed ID: 38724606
[TBL] [Abstract][Full Text] [Related]
6. DBF4 Dependent Kinase Inhibition Suppresses Hepatocellular Carcinoma Progression and Potentiates Anti-Programmed Cell Death-1 Therapy.
Zhang L; Hong J; Chen W; Zhang W; Liu X; Lu J; Tang H; Yang Z; Zhou K; Xie H; Jia C; Jiang D; Zheng S
Int J Biol Sci; 2023; 19(11):3412-3427. PubMed ID: 37497004
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of a Prognostic Model Based on Three MVI-Related Genes in Hepatocellular Carcinoma.
Tang Y; Xu L; Ren Y; Li Y; Yuan F; Cao M; Zhang Y; Deng M; Yao Z
Int J Biol Sci; 2022; 18(1):261-275. PubMed ID: 34975331
[TBL] [Abstract][Full Text] [Related]
8. Lactate induces aberration in the miR-30a-DBF4 axis to promote the development of gastric cancer and weakens the sensitivity to 5-Fu.
Wang T; Ji R; Liu G; Ma B; Wang Z; Wang Q
Cancer Cell Int; 2021 Nov; 21(1):602. PubMed ID: 34758839
[TBL] [Abstract][Full Text] [Related]
9. Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target.
Battista T; Fiorillo A; Chiarini V; Genovese I; Ilari A; Colotti G
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32268494
[TBL] [Abstract][Full Text] [Related]
10. Human Mesenchymal Stem Cells-mediated Transcriptomic Regulation of Leukemic Cells in Delivering Anti-tumorigenic Effects.
Sarmadi VH; Ahmadloo S; Boroojerdi MH; John CM; Al-Graitte SJR; Lawal H; Maqbool M; Hwa LK; Ramasamy R
Cell Transplant; 2020; 29():963689719885077. PubMed ID: 32024378
[TBL] [Abstract][Full Text] [Related]
11. Targeting CDC7 sensitizes resistance melanoma cells to BRAF
Gad SA; Ali HEA; Gaballa R; Abdelsalam RM; Zerfaoui M; Ali HI; Salama SH; Kenawy SA; Kandil E; Abd Elmageed ZY
Sci Rep; 2019 Oct; 9(1):14197. PubMed ID: 31578454
[TBL] [Abstract][Full Text] [Related]
12. A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma.
Song J; Merbs SL; Sokoll LJ; Chan DW; Zhang Z
Clin Proteomics; 2019; 16():10. PubMed ID: 30867659
[TBL] [Abstract][Full Text] [Related]
13. Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents that Target the Interaction with Dbf4 by the Fragment Complementation and Drug Repositioning Approach.
Cheng AN; Lo YK; Lin YS; Tang TK; Hsu CH; Hsu JT; Lee AY
EBioMedicine; 2018 Oct; 36():241-251. PubMed ID: 30293817
[TBL] [Abstract][Full Text] [Related]
14. Cell division cycle 7-kinase inhibitor PHA-767491 hydrochloride suppresses glioblastoma growth and invasiveness.
Erbayraktar Z; Alural B; Erbayraktar RS; Erkan EP
Cancer Cell Int; 2016; 16():88. PubMed ID: 27891063
[TBL] [Abstract][Full Text] [Related]
15. Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer.
Melling N; Muth J; Simon R; Bokemeyer C; Terracciano L; Sauter G; Izbicki JR; Marx AH
Diagn Pathol; 2015 Jul; 10():125. PubMed ID: 26208856
[TBL] [Abstract][Full Text] [Related]
16. The role of Dbf4-dependent protein kinase in DNA polymerase ζ-dependent mutagenesis in Saccharomyces cerevisiae.
Brandão LN; Ferguson R; Santoro I; Jinks-Robertson S; Sclafani RA
Genetics; 2014 Aug; 197(4):1111-22. PubMed ID: 24875188
[TBL] [Abstract][Full Text] [Related]
17. ATR-Chk1-APC/CCdh1-dependent stabilization of Cdc7-ASK (Dbf4) kinase is required for DNA lesion bypass under replication stress.
Yamada M; Watanabe K; Mistrik M; Vesela E; Protivankova I; Mailand N; Lee M; Masai H; Lukas J; Bartek J
Genes Dev; 2013 Nov; 27(22):2459-72. PubMed ID: 24240236
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-29a regulates the benzo[a]pyrene dihydrodiol epoxide-induced DNA damage response through Cdc7 kinase in lung cancer cells.
Barkley LR; Santocanale C
Oncogenesis; 2013 Jul; 2(7):e57. PubMed ID: 23877787
[TBL] [Abstract][Full Text] [Related]
19. Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival.
Masica DL; Karchin R
Cancer Res; 2011 Jul; 71(13):4550-61. PubMed ID: 21555372
[TBL] [Abstract][Full Text] [Related]
20. Molecular markers of tumor progression in melanoma.
Rother J; Jones D
Curr Genomics; 2009 Jun; 10(4):231-9. PubMed ID: 19949544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
